1-5 of 5
M.D. Cappellini
Close
Sort by
Journal Articles

Outcome of Thalassemia Intermedia Mothers and Newborns in Two Tertiary Care Centers, Beirut and Milan.

A. Taher, A. Nassar, M. Naja, C. Cesaretti, R. Fasulo, M.D. Cappellini
Journal: Blood
Blood (2007) 110 (11): 3827.
https://doi.org/10.1182/blood.V110.11.3827.3827
Published: 2007
Journal Articles

Long-Term Safety and Tolerability of the Once-Daily, Oral Iron Chelator Deferasirox (Exjade®, ICL670) in Patients with Transfusional Iron Overload.

M.D. Cappellini, P. Giardina, J. Porter, T. Coates, M.G. Della Porta, J. Siegel, E. Glimm, J. Ford
Journal: Blood
Blood (2006) 108 (11): 1768.
https://doi.org/10.1182/blood.V108.11.1768.1768
Published: 2006
Journal Articles

Long-Term Effects of Deferasirox (Exjade®, ICL670) on Serum Ferritin: Outcome of Dose Adjustments in Achieving Maintenance or Reduction in Body Iron Stores.

J.B. Porter, A. Cohen, L. Agaoglu, A. Ganser, M.D. Cappellini, H. Maseruka, E. Glimm, D. Alberti
Journal: Blood
Blood (2006) 108 (11): 1769.
https://doi.org/10.1182/blood.V108.11.1769.1769
Published: 2006
Journal Articles

Patient Satisfaction with Deferasirox (Exjade ® , ICL670) an Oral Form of Chelation Therapy Versus Deferoxamine an Infused Chelation Therapy.

M.D. Cappellini, M. Bejaoui, L. Agaoglu, M.E. Lai, A. Mangiagli, G. Strauss, R. Girot, H. Opitz, L. Abetz, J.F. Baladi, C. Ressayre-Djaffer, J. Ford
Journal: Blood
Blood (2005) 106 (11): 2704.
https://doi.org/10.1182/blood.V106.11.2704.2704
Published: 2005
Journal Articles

Nontransfusional Iron Overload in Thalassemia Intermedia: Role of the Hemochromatosis Allele

M.D. Cappellini, S.R. Fargion, M. Sampietro, G. Graziadei, G. Fiorelli
Journal: Blood
Blood (1998) 92 (11): 4479–4480.
https://doi.org/10.1182/blood.V92.11.4479
Published: 1998